The Implications of the Medicare Prescription Drug Benefit for Dual Eligibles

Three new reports focus on one of the biggest challenges in the implementation of the Medicare Modernization Act, the transitioning of drug coverage for individuals dually eligible for Medicaid and Medicare, who now get their drug coverage from Medicaid, to the new Medicare benefit.

The New Medicare Prescription Drug Law: Issues for Enrolling Dual Eligibles into Drug Plans

Medicare’s New Prescription Drug Benefit: The Voices of People Dually Covered by Medicare and Medicaid

Implications of The Medicare Modernization Act For States: Observations from a Focus Group Discussion with Medicaid Directors

Transitions: A Video Explores some of the issues and challenges “dual eligibles” may face during the transition from Medicaid drug coverage to Medicare.

These reports were released at a January 24, 2005 briefing:


Speaker Biographies

icon_presentations.gifPresentation – The Transition of Dual Eligibles to Medicare Drug Coverage: Implications for Beneficiaries and States; Jocelyn Guyer, Kaiser Family Foundation

Presentation – The Transition of Dual Eligibles’ Drug Coverage from Medicaid to Medicare Part D: Issues and Options; Julie James, Health Policy Alternatives

Audio Webcast: Real Player or Windows Media Player


Related Documents:

Dual Eligibles Tables: Enrollment and Spending, by State, 2002

Medicare Prescription Drug Improvement and Modernization Act Implementation Timeline: June 2004 – December 2006 Key Dates

The Medicare Prescription Drug Law – Fact Sheet

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.